Close

Gilead Sciences (GILD) Announces Tipline Data from Four Sofosbuvir , Velpatasvir, Voxilaprevir Phase 3s in Genotype 1 - 6 HCV

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/23/2024

1. GM
2. TSLA
3. SPY
4. CPRI
5. NVDA
6. ADBE
7. MTTR
8. TPR
9. LMT
10. CLF


Go back to Gilead Sciences (GILD) Announces Tipline Data from Four Sofosbuvir , Velpatasvir, Voxilaprevir Phase 3s in Genotype 1 - 6 HCV
Gilead Sciences (NASDAQ: GILD) Delayed: 66.95 --0 (-0%)
Previous Close $66.95    52 Week High $108.63 
Open $66.95    52 Week Low $71.39 
Day High $66.95    P/E 36.99 
Day Low $66.95    EPS $1.81 
Volume 29